Sunday, January 11, 2026

 

Behind nature’s blueprints



ISTA physicists create ‘theoretical rulebook’ of self-assembly




Institute of Science and Technology Austria

Ability to build 

image: 

Biology has long fascinated physicists with its ability to build complex molecular machines from self-assembling building blocks. 

view more 

Credit: © ISTA




Inspired by biological systems, materials scientists have long sought to harness self-assembly to build nanomaterials. The challenge: the process seemed random and notoriously difficult to predict. Now, researchers from the Institute of Science and Technology Austria (ISTA) and Brandeis University have uncovered geometric rules that act as a master control panel for self-assembling particles. The results, which could find applications ranging from protein design to synthetic nanomachines, were published in Nature Physics.

Life is the ultimate nanotechnologist. Biology has long fascinated physicists with its ability to build complex molecular machines and structures from molecules that snap into place like magnets. But what governs this phenomenon that frequently occurs in nature?

To find out, PhD student Maximilian Hübl and Assistant Professor Carl Goodrich from the Institute of Science and Technology Austria (ISTA) teamed up with scientists Daichi Hayakawa and Thomas Videbaek from W. Benjamin Rogers’ group at Brandeis University in the United States. Together, they set out to crack the code of molecular self-assembly and apply it to nanotechnology. “For decades, scientists have dreamed of harnessing the power of molecular self-assembly to build custom-made nanomaterials,” says Goodrich. “But a major challenge has been predicting exactly what shapes will form when thousands of tiny pieces are set in motion.” In a dual approach that combines theoretical and experimental methods, the team developed and validated a tool that distinguishes ‘designable’ or viable structures from those that cannot be assembled. As it turns out, the outcomes of self-assembly are governed by geometry.

Light in the darkness

Self-assembling particles are not exactly new to Goodrich’s research interests. However, he was only convinced to tackle the topic head-on after developing a concrete approach to address it. His initial strategy encompassed numerical calculations, including automatic differentiation and differentiable programming. When Hübl joined the Goodrich group at ISTA, he started examining the project using this same approach. However, he quickly identified a more general and effective method. “With our initial strategy, we looked at the problem as if we were inside an unknown room, in pitch darkness, searching around with a flashlight. Eventually, we realized the room had a light switch. Turning the lights on allowed us to view all the possibilities that self-assembly can achieve, as well as the areas it cannot access.” Thus, it turns out that self-assembly is far from a random process in a vast ocean of mathematical possibilities. By finding the right approach, the team was able to clarify the limits between feasible and infeasible self-assembly configurations.

Rulebook of a hidden geometric shape

With Hübl’s method, the team focused on the effects of tuning the concentrations and binding energies of assembling particles. Eventually, this approach would help them determine which sets of structures are ‘designable.’

“We used the binding energies as input for the calculation. As an output, we determined what structures will be formed by the particles, and in what quantities,” Hübl explains. “This allowed us to identify constraints that prevent certain outcomes from ever occurring in particles.” An example of such constraints is that obtaining a specific structure with 100 percent yield may be plainly impossible. In such a case, an additional structure might be what the scientists call a ‘necessary chimera,’ meaning an inevitable byproduct that is thermodynamically unavoidable under these conditions. Goodrich underlines, “Our method could explain why some attempts at designing specific nanomaterials are especially challenging.”

But what theoretical framework did the scientists identify, precisely? Together, the computed thermodynamic constraints form a hidden mathematical shape that captures the range of possible assembly outcomes: a ‘high-dimensional convex polyhedron.’ This geometric shape would serve as the ‘theoretical rulebook’ of self-assembly in equilibrium. “The polyhedral structure demonstrates that equilibrium assemblies follow rules that could serve as tools for nanotechnologists and molecular designers,” Goodrich explains. “This underlying physics tells us whether a given target structure is possible at all.”

DNA origami

To test the practical utility of this geometric shape that governs self-assembly, the ISTA scientists teamed up with researchers from the Rogers group at Brandeis, who use techniques from biological physics and soft matter physics to understand self-assembly. They designed and synthesized triangular DNA origami building blocks and devised experiments to validate the theory. By extending single-stranded DNA from the triangles’ sides and adjusting their sequences to program specific interactions, they implemented a set of theoretical binding rules experimentally. “We found striking quantitative agreement between the theory and experiment, confirming that we had indeed uncovered some of the fundamental rules of assembly,” says Rogers.

According to the authors, the experimental results are clear evidence of the theory’s real-world applicability. “Essentially, we used our geometric ‘rulebook’ to predict the experimental outcomes without modeling the details of the interactions. The experiments closely matched the predicted results, without us having to review any part of the theory or adjust any factors,” says Hübl. Consequently, besides identifying ‘designable’ structures, the ‘theoretical rulebook’ has proven its practical worth.

Nature’s playground & its blueprints

By uncovering the underlying geometry that draws the line between what is possible to build and what is impossible to create, the team demonstrated the limits of self-assembly. “Self-assembly is that grand, crazy thing that nature does. But Max’s theory now explains why some attempts to replicate this don't work, and how they could be done better. It’s like having a blueprint that traces the boundaries of nature’s playground. Ultimately, this model could serve as an architect’s tool, a master control panel for designing nanostructures,” says Goodrich.

According to the team, applications will likely include inverse design in a wide range of experimental settings, such as de novo protein assembly from smaller building blocks, DNA nanoparticles, and synthetic nanomachines.

The theoretical model developed at the Institute of Science and Technology Austria (ISTA) could serve as a master control panel for designing nanostructures. PhD student Maximilian Hübl and Assistant Professor Carl Goodrich with a simplified toy model. 

The ISTA team’s theoretical model could serve as a master control panel for designing nanostructures. PhD student Maximilian Hübl and Assistant Professor Carl Goodrich with a simplified toy model.


 

Mapping proteins in African genomes reveals new paths to fight type 2 diabetes




Helmholtz Munich (Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH))





Researchers have conducted the most comprehensive analysis to date linking plasma proteins to genetic variation in individuals from continental Africa. Their work addresses a long-standing gap by studying a population grossly underrepresented in medical research. The findings could pave the way for earlier and more accurate type 2 diabetes diagnoses, as well as treatments tailored to African populations. The study was led by Helmholtz Munich in collaboration with the Queen Mary University of London, the Technical University of Munich and the Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit.

Closing an Equity Gap in Global Health
Type 2 diabetes (T2D) is a growing health concern in sub-Saharan Africa, but it is often underdiagnosed or misdiagnosed. This is partly because most existing diagnostic markers, such as glycated hemoglobin (HbA1c), were developed in European populations and may be less accurate in African populations due to genetic and biological differences. Until now, there is a critical lack of large-scale genetic and proteomic studies in continental Africa, leaving major blind spots in the development of effective diagnostic and therapeutic strategies for these communities.

“By focusing on African populations, we are uncovering biological insights that have been missing from global diabetes research,” says Dr. Opeyemi Soremekun, first author of the study and former Humboldt Research Fellow at Helmholtz Munich. “This work shows that a one-size-fits-all approach to diagnosis and treatment is not enough – we need solutions that reflect the diversity of human biology.”

Unique Protein Patterns Provide New Insights Into Disease Biology
By combining genomic and plasma proteomic data from a Ugandan cohort, the researchers mapped nearly 400 genetic regions that regulate circulating protein levels – 58 of them previously unknown in African-ancestry individuals. They identified 18 proteins with a likely causal link to T2D, including some that could be targeted by existing drugs. Notably, several proteins (such as apolipoprotein F and lipoprotein lipase) showed unique patterns in the Ugandan participants but not in Europeans, underscoring the importance of population-specific insights. These results not only deepen scientific understanding of T2D biology but also provide a publicly available dataset for researchers worldwide.

“Our analysis identified protein changes and genetic signals that are specific to African ancestry populations,” says Prof. Segun Fatumo, Chair of the Precision Healthcare University Research Institute at Queen Mary University of London. “These findings highlight potential new biomarkers for type 2 diabetes and open the door to treatments that are tailored to the biological profiles of these communities.”

Expanding Research to Reflect Africa’s Diversity
The team plans to expand this work to additional African populations, recognizing that the continent’s genetic, cultural, dietary, and environmental diversity means that type 2 diabetes does not follow a single biological pattern. By mapping these differences in detail, the research could help develop representative biomarkers and treatment strategies – ultimately bringing more precise and effective healthcare to millions of people.

“Our findings lay the groundwork for future clinical applications, from improved diagnostic markers to potential therapeutic targets,” says Prof. Eleftheria Zeggini, Director of the Institute of Translational Genomics at Helmholtz Munich and Professor at the Technical University of Munich. “By embracing genetic diversity in research, we can move closer to precision medicine that works for all.”

About the Researchers
Dr. Opeyemi Soremekun, Carl Friedrich von Siemens Research Fellow of the Alexander von Humboldt Foundation at the Institute of Translational Genomics at Helmholtz Munich until September 2025; researcher at the Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit and at the University of KwaZulu-Natal, South Africa.
Prof. Segun Fatumo, Chair of the Precision Healthcare University Research Institute at the Queen Mary University of London; researcher at the Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit and at the Institute of Translational Genomics at Helmholtz Munich.
Prof. Eleftheria Zeggini, Director of the Institute of Translational Genomics at Helmholtz Munich and Professor of Translational Genomics at the Technical University of Munich (TUM).

About Helmholtz Munich
Helmholtz Munich is a leading biomedical research center. Its mission is to develop breakthrough solutions for better health in a rapidly changing world. Interdisciplinary research teams focus on environmentally triggered diseases, especially the therapy and prevention of diabetes, obesity, allergies, and chronic lung diseases. With the power of artificial intelligence and bioengineering, researchers accelerate the translation to patients. Helmholtz Munich has around 2,500 employees and is headquartered in Munich/Neuherberg. It is a member of the Helmholtz Association, with more than 43,000 employees and 18 research centers the largest scientific organization in Germany. More about Helmholtz Munich (Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH): www.helmholtz-munich.de/en

 

What if ADHD risk isn’t fixed at birth, but shaped by how early environments interact with a child’s sensitivity?




Ben-Gurion University of the Negev
Figure 1 

image: 

Simple slopes and Johnson–Neyman plot for the interaction between infant surgency and early home environment. Panel A presents the simple slopes pattern of the interaction between neonatal surgency and the home environment. Panel B shows the Johnson–Neyman region of significance analysis for the slope of the early home environment, as a function of neonatal surgency levels; significant regions (in blue, p < 0.05) indicate that the early home environment significantly predicts child EF (executive function) for infants with these levels of neonatal surgency. Panel C shows the Johnson–Neyman region of significance analysis for the slope of neonatal surgency, as a function of early home environment levels; significant regions (in blue, p < 0.05) indicate that neonatal surgency significantly predicts child EF at specific levels of the early home environment.

view more 

Credit: Prof. Andrea Berger/BGU





BEER-SHEVA, Israel, January 8, 2026 – A 17-year longitudinal study from Ben-Gurion University of the Negev followed children from birth to adolescence to explore whether early-life factors can predict ADHD, and for whom the environment matters most.

Published in Infant and Child Development (https://doi.org/10.1002/icd.70072), the study tracked ~125 children and their parents, examining infant temperament, parental ADHD symptoms, and the richness of the early home environment.

The key finding: Early “risk factors” don’t affect all children equally.

Led by Profs. Andrea Berger and Judith G. Auerbach (BGU), together with Dr. Tzlil Einziger, the researchers found that infants showing high motor activity, especially those with parents who have elevated ADHD symptoms — were more sensitive to their environment.

For these children, a rich and supportive home environment strongly predicted better cognitive functioning by age 7, which in turn was linked to fewer ADHD symptoms in later childhood and adolescence. The same sensitivity meant they benefited most from supportive environments — and were more negatively affected by less enriching ones.

"There aren’t just “sensitive” and “non-sensitive” children," explains Prof. Berger, "Sensitivity exists on a continuum, shaped by the interaction between child temperament and parental characteristics."

"Understanding this can help tailor early environments to better support children who need it most," concludes Prof. Auerbach.

Additional researchers included: Prof. Naama Atzaba-Poria, Drs. Rivka Landau, Shoshana Arbelle and Michael Karplus.

The study was supported by the Israel Science Foundation (ISF) (Grant Nos. 756/98-01, 869-01, 1058/16).

 

Hybrid parasites threaten progress against one of the world’s most widespread neglected diseases



Liverpool School of Tropical Medicine





New research led by Liverpool School of Tropical Medicine (LSTM) warns that hybrid forms of the parasites that cause schistosomiasis are undermining existing disease control strategies and could accelerate the spread of infection in Africa and beyond.

Schistosomiasis is a disease caused by water borne schistosome parasites that affects more than 200 million people worldwide, causing chronic illness, disability and, in severe cases, life threatening organ damage. Despite decades of large-scale control programmes based on mass drug administration, transmission remains stubbornly persistent in many settings, particularly where people depend on freshwater for daily activities.

A major new Special Issue of Philosophical Transactions B of the Royal Society brings together 12 multidisciplinary studies showing that schistosome parasites are hybridising far more frequently than previously recognised. These hybrids emerge when different parasite species, including those infecting humans and livestock, mix and reproduce in shared freshwater environments.

Researchers found that some hybrid parasites can display altered biological traits, including changes linked to virulence, host range and transmission potential. These changes complicate diagnosis, as hybrid eggs can be harder to identify using standard methods, and raise concerns that current control strategies, which largely focus on treating human infection alone, may be missing key reservoirs of disease.

Several researchers also warn that hybrids are already reshaping patterns of schistosomiasis across Africa and could enable the disease to establish in new regions. Previous outbreaks of urogenital schistosomiasis in southern Europe have shown that transmission outside Africa is possible when animal and human parasites overlap, highlighting the need for stronger surveillance.

Professor Russell Stothard from LSTM is the senior author on several papers and the co-editor of the Special Issue. He said: “Schistosomes are demonstrating parasite evolution in action with remarkable speed. This new body of work reveals a level of biological complexity and flexibility that changes how we appreciate African schistosomes, classify them and hope to mitigate their detrimental impact”.

“Hybrid schistosomes are not unusual biological outliers, they are becoming a central part of the epidemiological landscape. This raises important questions for future disease surveillance, particularly genital schistosomiasis, and associated treatment strategies that should better embrace One Health approaches.”

The studies show that hybridisation is driving the emergence of new variants in both northern and southern Africa, each responding differently to ecological and agricultural pressures. One hybrid variant, Schistosoma haematobium x S. mattheei, which links a human-infecting species with a livestock species, is now a common cause of genital tract disease in men and women in parts of Malawi, underscoring the blurred boundaries between human and animal health.

Together, the authors argue that without improved surveillance, including genetic monitoring of parasites, and greater integration of human, animal and environmental health strategies, hybrid schistosomes could slow or reverse progress towards elimination targets.

Professor Janelisa Musaya, Associate Director at Malawi Liverpool Wellcome Programme (MLW), said: “In Malawi, we have observed a disturbing trend of persistent infection, particularly in areas where people and livestock coexist, despite over a decade of annual mass drug administration. These landmark studies finally help us unravel the mystery behind this resilience, revealing how hybridisation between human and animal parasites complicates the path to elimination.

“This evidence is a call to action for our national control programmes to adopt a 'One Health' approach that addresses the blurred boundaries between human and animal health.”

The Special Issue, Parasite evolution and impact in action: Exploring the importance and control of hybrid schistosomes in Africa and beyond, is published by the Royal Society and will be available from 8 January.

Five of the papers are led by LSTM scientists, with several arising from the Wellcome funded HUGS project, a major collaboration between Liverpool School of Tropical Medicine and the Malawi Liverpool Wellcome Programme.

ENDS